Literature DB >> 33963190

Pulmonary function testing in COPD: looking beyond the curtain of FEV1.

Sotirios Kakavas1, Ourania S Kotsiou2, Fotis Perlikos3, Maria Mermiri4, Georgios Mavrovounis5, Konstantinos Gourgoulianis2, Ioannis Pantazopoulos5.   

Abstract

Chronic obstructive pulmonary disease (COPD) management remains challenging due to the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the disease. Airflow limitation, diagnosed by spirometry, remains the cornerstone of the diagnosis. However, the calculation of the forced expiratory volume in the first second (FEV1) alone, has limitations in uncovering the underlying complexity of the disease. Incorporating additional pulmonary function tests (PFTs) in the everyday clinical evaluation of COPD patients, like resting volume, capacity and airway resistance measurements, diffusion capacity measurements, forced oscillation technique, field and cardiopulmonary exercise testing and muscle strength evaluation, may prove essential in tailoring medical management to meet the needs of such a heterogeneous patient population. We aimed to provide a comprehensive overview of the available PFTs, which can be incorporated into the primary care physician's practice to enhance the efficiency of COPD management.

Entities:  

Year:  2021        PMID: 33963190     DOI: 10.1038/s41533-021-00236-w

Source DB:  PubMed          Journal:  NPJ Prim Care Respir Med        ISSN: 2055-1010            Impact factor:   2.871


  128 in total

Review 1.  Clinical phenotypes of COPD: identification, definition and implications for guidelines.

Authors:  Marc Miravitlles; Myriam Calle; Juan José Soler-Cataluña
Journal:  Arch Bronconeumol       Date:  2011-12-22       Impact factor: 4.872

Review 2.  Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care.

Authors:  Shireen Mirza; Roberto Benzo
Journal:  Mayo Clin Proc       Date:  2017-07       Impact factor: 7.616

Review 3.  Phenotyping Before Starting Treatment in COPD?

Authors:  Nikolaos Siafakas; Alexandru Corlateanu; Evangelia Fouka
Journal:  COPD       Date:  2017-04-07       Impact factor: 2.409

4.  Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD.

Authors:  Gianna Camiciottoli; Francesca Bigazzi; Matteo Paoletti; Lucia Cestelli; Federico Lavorini; Massimo Pistolesi
Journal:  Eur Respir J       Date:  2012-12-20       Impact factor: 16.671

5.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.

Authors:  B Burrows; J W Bloom; G A Traver; M G Cline
Journal:  N Engl J Med       Date:  1987-11-19       Impact factor: 91.245

6.  Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011.

Authors:  Raquel Marçôa; Daniela Marta Rodrigues; Margarida Dias; Inês Ladeira; Ana Paula Vaz; Ricardo Lima; Miguel Guimarães
Journal:  COPD       Date:  2017-11-21       Impact factor: 2.409

Review 7.  The COPD control panel: towards personalised medicine in COPD.

Authors:  Alvar Agusti; William MacNee
Journal:  Thorax       Date:  2012-11-01       Impact factor: 9.139

8.  Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.

Authors:  Jørgen Vestbo; Alvar Agusti; Emiel F M Wouters; Per Bakke; Peter M A Calverley; Bartolome Celli; Harvey Coxson; Courtney Crim; Lisa D Edwards; Nicholas Locantore; David A Lomas; William MacNee; Bruce Miller; Stephen I Rennard; Edwin K Silverman; Julie C Yates; Ruth Tal-Singer
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

9.  COPD phenotypes on computed tomography and its correlation with selected lung function variables in severe patients.

Authors:  Silvia Maria Doria da Silva; Ilma Aparecida Paschoal; Eduardo Mello De Capitani; Marcos Mello Moreira; Luciana Campanatti Palhares; Mônica Corso Pereira
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-16

Review 10.  Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.

Authors:  Peter Lange; David M Halpin; Denis E O'Donnell; William MacNee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-02-19
View more
  4 in total

1.  Effect of humidified high-flow nasal cannula oxygen therapy on respiratory function recovery in stable COPD patients.

Authors:  Ruibing Lyu; Wen Wang; Wenju Wang; Nian Liu; Jinwen Xiao; Xin Li
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  General Anesthesia for Patients With Chronic Obstructive Pulmonary Disease and Postoperative Respiratory Failure: A Retrospective Analysis of 120 Patients.

Authors:  Ruixue Hou; Fangfang Miao; Di Jin; Qingfang Duan; Cheng Yin; Qunpeng Feng; Tianlong Wang
Journal:  Front Physiol       Date:  2022-05-30       Impact factor: 4.755

3.  The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Chin-Ling Li; Mei-Hsin Lin; Yuh-Chyn Tsai; Ching-Wan Tseng; Chia-Ling Chang; Lien-Shi Shen; Ho-Chang Kuo; Shih-Feng Liu
Journal:  J Clin Med       Date:  2022-03-29       Impact factor: 4.241

4.  FVC, but not FEV1, is associated with clinical outcomes of asthma-COPD overlap.

Authors:  Tai Joon An; Chin Kook Rhee; Yong Bum Park; Kwang-Ha Yoo; Hyoung Kyu Yoon
Journal:  Sci Rep       Date:  2022-08-15       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.